Wolverhampton named as one of areas in England facing greatest obesity-related healthcare pressures

Wolverhampton has been named one of England's obesity care hotspots based on a new report by The Independent Pharmacy.

The study, conducted by The Independent Pharmacy, analysed obesity prevalence data alongside median waiting times for obesity-related treatment across English NHS trust areas.

Each area was given a combined pressure index score based on the proportion of adults living with obesity and the median number of weeks patients wait for obesity-related care, revealing where high levels of need and delays in access to support are colliding.

The analysis found that Wolverhampton ranks tenth in England, with 31.1 percent of adults living with obesity and patients facing median waits of 18.2 weeks for obesity-related treatment.

It also scored an overall pressure index of 45.6.

The data found that Northern Lincolnshire & Goole topped the overall pressure index with a score of 55.9, driven by a 35.1 percent obesity rate and a median wait of 17 weeks for treatment.

Gateshead followed closely in second, recording the highest obesity prevalence in the dataset, with 37.2 percent of adults living with obesity. This means more than one in three adults in the area is obese, placing significant demand on local services.

Speaking on the study, Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, said: “Our study highlights the areas where high obesity rates and long NHS waits are combining to create significant pressure on local services.

“In places where more than one in three adults are living with obesity, demand for support is already high. When patients in those areas are also waiting weeks or months for care, the risk is that obesity-related conditions continue to worsen before help is available.

“This is not only a waiting list issue, but a wider prevention challenge. Obesity is closely linked to long-term conditions such as type 2 diabetes, heart disease and stroke, which can become more complex to treat when support is delayed.

“Areas such as Northern Lincolnshire & Goole, Gateshead and Stoke-on-Trent show how high prevalence and delayed access to care can collide, placing greater pressure on patients, clinicians and NHS services.

“Improving access to early intervention, community-based support and appropriate treatment options is essential if the NHS is to reduce demand before patients reach a more serious stage of illness.”